You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. N/A

    SBC: XIDEX CORPORATION            Topic: N/A

    N/A

    STTR Phase II 1999 Department of DefenseArmy
  2. Therapy for gastrointestinal disorders

    SBC: AGENNIX, INC.            Topic: N/A

    DESCRIPTION (Applicant's Abstract): The overall goal of this research proposal is to determine the effectiveness of recombinant human lactoferrin (rhLF) for treating gastrointestinal (GI) disorders. This Phase II proposal will focus on the ability of rhLF to treat the 01 side effects of non-steroidal anti-inflammatory drugs (NSAIDs), a class of drugs widely-us ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  3. Drug Delivery System for Superficial Mycoses

    SBC: Biomedical Development Corporation            Topic: N/A

    DESCRIPTION (Provided by the applicant): The goal of this project is to establish the safety and efficacy of a unique drug delivery system for use as a sustained-release, antifungal skin preparation for the treatment of superficial mycoses. The lifetime risk of acquiring a superficial mycotic infection is estimated to be between 10 and 20 percent. In the U.S., annu ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Activated Organophosphate Hydrolase for Coupling to Human Skin

    SBC: LYNNTECH INC.            Topic: N/A

    This Phase II STTR proposal describes an activated form of organophosphate hydrolyzing enzyme that, when dissolved in water, forms a covalent bond to skin. In Phase I, a lyophilized preparation of Organophosphate Hydrolase (OPH) from Pseudomonas diminutaretained the capability to couple to skin and to hydrolyze nerve agent surrogates when stored for months at 40¿C. Immobilized enzyme also retai ...

    STTR Phase II 2001 Department of DefenseArmy
  5. DEVELOPMENT OF POLY-L-GLUTAMIC ACID PACLITAXEL CONJUGATE

    SBC: FEM CADET            Topic: N/A

    Chemoradiation improves survival for patients with locally advanced non-small cell lung cancer (NSCLC) over radiotherapy (R) alone. Les than 20% of patients have complete pathologic response to combination therapy. Paclitaxel (TXL) is effective as an anti-tumor agent and a radiosensitizer. Peripheral neurotoxicity and granulocytopenia limit its dosage; acute effects from TXL's infusion include na ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  6. VALIDATION OF TRANSILLUMINATION AND THE NEVOSCOPE

    SBC: TRANSLITE            Topic: N/A

    DESCRIPTION (provided by applicant): Skin cancer is the most common of all cancers and melanoma is a deadly skin cancer that accounts for over 75% of all the skin cancer deaths in the United States. The incidence of melanoma is rising at approximately 3% per year. Early detection of melanoma results in 95% cure rate. But, early detection of melanoma is difficult because of the subtle changes that ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  7. Gene Therapy for Human Malignant Melanoma

    SBC: Introgen Therapeutics, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Melanoma is the most malignant of skin cancers. In the USA, the incidence of melanoma is increasing more rapidly than any other cancer. Melanoma is the most frequently occurring cancer in women from the ages of 25-30, and has recently replaced leukemia as responsible for the most lost work hours in the United States. Currently there is no approved therapy tha ...

    STTR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health
  8. Nuclear Magnetic Resonance Force Microscopy Using Ultrasensitive Oscillators

    SBC: XIDEX CORPORATION            Topic: N/A

    Xidex and The University of Texas at Austin have successfully demonstrated the feasibility of developing a magnetic resonance force microscope for single proton imaging. Our Phase II work will demonstrate use of high-precision, high-sensitivitymeasurement of the magnetic force using (a) the high-Q mode of multiple torsional oscillators fabricated from single crystal silicon as the sensing element ...

    STTR Phase II 2003 Department of DefenseArmy
  9. Development of a Peptide Microchip System

    SBC: ATACTIC TECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The purpose of this proposal is to develop a protein assay technology that will parallel the newly developing oligonucleotide microarray techniques. We will develop a peptide system capable of performing high throughput real time measurements in parallel on a microfluidic chip. We will develop the chemistry to prepare these chips in Phase I and develop the s ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Novel CSF biomarker to predict impaired cognition in HIV

    SBC: INFLAME THERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The focus of this project is to explore the relationship between inflammatory cells and cognitive dysfunction in populations with HIV-1 infection. Extensive work has found that a biomarker is detected in lumbar cerebrospinal fluid of HIV(+) subjects with impaired cognition. Presently there are no suitable clinical tests to identify early neuro-inflammatory inju ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government